Drug intelligence / Profile preview

xylometazoline + dexpanthenol

Development stage
Phase 3
Lead developer
M.C.M. Klosterfrau
Modality
Small Molecules
Administration
Intranasal
01

Overview

**Nasic** is an intranasal fixed-dose nasal spray combining xylometazoline hydrochloride, a sympathomimetic alpha-adrenergic agonist that constricts nasal mucosal blood vessels and reduces mucosal swelling, with dexpanthenol, a pantothenic-acid precursor that supports epithelial protection and mucosal wound healing. Developed by Klosterfrau, it is marketed for relief of nasal congestion during rhinitis including the common cold, vasomotor rhinitis, acute rhinosinusitis-associated rhinitis, and impaired nasal breathing after nasal surgery. Standard Nasic nasal spray contains xylometazoline hydrochloride 1 mg/mL and dexpanthenol 50 mg/mL and is intended for adults and children aged 6 years and older. ([nasic.de](https://www.nasic.de/die-produkte/nasic-nasenspray))

Brand names
Nasic
Other names
xylometazoline hydrochloride + dexpanthenol
02

Targets

ADRA1A (α1A)ADRA2A (α2A)

Beyond the preview

Go deeper on xylometazoline + dexpanthenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xylometazoline + dexpanthenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call